Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19
Sattui S, Liew J, Graef E, Coler-Reilly A, Berenbaum F, Duarte-García A, Harrison C, Konig M, Korsten P, Putman M, Robinson P, Sirotich E, Ugarte-Gil M, Webb K, Young K, Kim A, Sparks J. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Review Of Clinical Immunology 2020, 16: 659-666. PMID: 32620062, PMCID: PMC7594186, DOI: 10.1080/1744666x.2020.1792778.Peer-Reviewed Original ResearchCapturing Patient‐Reported Outcomes During the COVID‐19 Pandemic: Development of the COVID‐19 Global Rheumatology Alliance Patient Experience Survey
Sirotich E, Dillingham S, Grainger R, Hausmann J, Robinson P, Yazdany J, Grainger R, Wallace Z, Bhana S, Sirotich E, Liew J, Hausmann J, Machado P, Costello W. Capturing Patient‐Reported Outcomes During the COVID‐19 Pandemic: Development of the COVID‐19 Global Rheumatology Alliance Patient Experience Survey. Arthritis Care & Research 2020, 72: 871-873. PMID: 32386125, PMCID: PMC7272930, DOI: 10.1002/acr.24257.Peer-Reviewed Original ResearchCharacteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
Gianfrancesco M, Hyrich K, Al-Adely S, Carmona L, Danila M, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus E, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham K, Bhana S, Costello W, Grainger R, Hausmann J, Liew J, Sirotich E, Sufka P, Wallace Z, Yazdany J, Machado P, Robinson P. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Annals Of The Rheumatic Diseases 2020, 79: 859-866. PMID: 32471903, PMCID: PMC7299648, DOI: 10.1136/annrheumdis-2020-217871.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAnti-Inflammatory Agents, Non-SteroidalAntimalarialsAntirheumatic AgentsArthritis, PsoriaticArthritis, RheumatoidBetacoronavirusBiological ProductsCoronavirus InfectionsCOVID-19FemaleGlucocorticoidsHospitalizationHumansJanus Kinase InhibitorsLupus Erythematosus, SystemicMaleMiddle AgedMultivariate AnalysisPandemicsPneumonia, ViralPrednisoneProtective FactorsRegistriesRheumatic DiseasesRisk FactorsSARS-CoV-2Severity of Illness IndexSpondylarthropathiesTumor Necrosis Factor InhibitorsVasculitisYoung AdultConceptsDisease-modifying antirheumatic drugsRheumatic diseasesHospitalisation statusHigher oddsNon-steroidal anti-inflammatory drug useConventional disease-modifying antirheumatic drugsAnti-inflammatory drug useOdds of hospitalisationRheumatic disease diagnosisRheumatic disease medicationsMultivariable-adjusted modelsMultivariable logistic regressionJanus kinase inhibitorCOVID-19 outcomesCOVID-19Prednisone doseAntirheumatic drugsGlucocorticoid exposureInhibitor useAntimalarial useClinical factorsCase seriesSmoking statusReduced oddsDecreased oddsThe Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance
Wallace Z, Bhana S, Hausmann J, Robinson P, Sufka P, Sirotich E, Yazdany J, Grainger R. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. Rheumatology 2020, 59: 1204-1206. PMID: 32374851, PMCID: PMC7239169, DOI: 10.1093/rheumatology/keaa191.Peer-Reviewed Original ResearchFestina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist
Graef E, Liew J, Putman M, Simard J, Sirotich E, Berenbaum F, Duarte-García A, Grainger R, Harrison C, Konig M, Korsten P, Proulx L, Richards D, Robinson P, Sattui S, Ugarte-Gil M, Young K, Kim A, Sparks J. Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Annals Of The Rheumatic Diseases 2020, 79: 734-736. PMID: 32295786, PMCID: PMC7359879, DOI: 10.1136/annrheumdis-2020-217480.Peer-Reviewed Original ResearchA Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19
Kim A, Sparks J, Liew J, Putman M, Berenbaum F, Duarte-García A, Graef E, Korsten P, Sattui S, Sirotich E, Ugarte-Gil M, Webb K, Grainger R, . A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Annals Of Internal Medicine 2020, 172: m20-1223. PMID: 32227189, PMCID: PMC7138335, DOI: 10.7326/m20-1223.Peer-Reviewed Original Research